Dirk de Ruysscher (D.K.M.)

Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., West, C., Kerns, S., Azria, D., Farcy-Jaquet, M. P., Chang-Claude, J., Dunning, A., Lambrecht, M., Avuzzi, B., De Ruysscher, D., Seibold, P., Sperk, E., Talbot, C., Vega, A., Veldeman, L., Bultijnck, R., ... McWilliam, A. (2026). Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial. Radiotherapy and Oncology, 222, Article 111673. https://doi.org/10.1016/j.radonc.2026.111673

Jaikuna, T., Dawes, I., Chamberlin, H., Azria, D., Chang-Claude, J., De Santis, M. C., Gutierrez-Enriquez, S., van Herk, M., Hoskin, P., Kotzki, L., Defraene, G., Lambrecht, M., Lingard, Z., Seibold, P., Seoane, A., Sperk, E., Symonds, R. P., Talbot, C. J., Rancati, T., ... Aznar, M. C. (2026). Technical note: reconstructing dose distributions from manually planned electron boosts in breast radiotherapy. Physica Medica: European journal of medical physics, 149, Article 107169. https://doi.org/10.1016/j.ejmp.2026.107169

Jongbloed, M., De Ruysscher, D. K. M., & Hendriks, L. E. L. (2026). Concerns Regarding NSCLC Immunoradiotherapy Study Interpretability. JAMA Oncology. Advance online publication. https://doi.org/10.1001/jamaoncol.2026.2921

Aguado-Barrera, M. E., Calvo-Crespo, P., Taboada-Valladares, B., Gomez-Caamano, A., Carracedo, A., Azria, D., Briers, E., Chang-Claude, J., de Ruysscher, D., Defraene, G., Elliott, R. M., Faivre-Finn, C., Franceschini, M., Fuentes-Rios, O., Giraldo, A., Giandini, T., Gutierrez-Enriquez, S., Heumann, P., Higginson, D. S., ... REQUITE consortium (2026). Early and late CTCAE and patient-reported outcomes following lung cancer radiotherapy: A sex-stratified descriptive analysis from the REQUITE cohort. Clinical and Translational Radiation Oncology, 61, Article 101265. Advance online publication. https://doi.org/10.1016/j.ctro.2026.101265

van Rossum, P. S. N., Damen, P. J. J., Cortiula, F., Hobbs, B. P., De Marchi, L., Mohan, R., Peters, M., Schneiders, F. L., De Ruysscher, D., Wijsman, R., Verhoeff, J. J. C., Xu, T., Liao, Z., & Lin, S. H. (2026). Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC. International Journal of Radiation Oncology Biology Physics, 125(5), 1434-1444. https://doi.org/10.1016/j.ijrobp.2026.02.238

Lyu, S., Reynders, K., Laven, I. E. W. G., Faes, C., Weynand, B., Hillen, L. M., De Leyn, P., Hendriks, L. E. L., Wauters, E., Lambrecht, M., Vaes, R. D. W., & De Ruysscher, D. (2026). Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study. Translational Lung Cancer Research, 15(7), Article 200. https://doi.org/10.21037/tlcr-2026-1-0017

Sugden, B. M., Witlox, W. J. A., Cortiula, F., Hendriks, L. E. L., van Loon, J., Jacobs, M., Hattu, D., Joore, M. A., Ramaekers, B. L. T., & De Ruysscher, D. K. M. (2026). Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer. Clinical and Translational Radiation Oncology, 59, Article 101160. https://doi.org/10.1016/j.ctro.2026.101160

Heumann, P., Romero, J. C. R., Aguado Barrera, M. E., Aguado Flor, E., Avuzzi, B., Azria, D., Briers, E., Carballo-Castro, A., Chang-Claude, J., Choudhury, A., Dunning, A., Elliott, R. M., Fachal, L., Farcy-Jacquet, M. P., Gómez-Caamaño, A., Gutiérrez-Enríquez, S., Herskind, C., Kaaks, R., Kerns, S. L., ... REQUITE/REQUITEplus/RADprecise consortia (2026). Early and late CTCAE and patient-reported outcomes following prostate radiotherapy in the REQUITE cohort. Clinical and Translational Radiation Oncology, 60, Article 101219. https://doi.org/10.1016/j.ctro.2026.101219

Peters, S., Tan, D. S. W., Gerber, D. E., Urbanic, J., Ramalingam, S., Yu, J., Xing, L., Rittmeyer, A., Ciuleanu, T.-E., de Menezes, J., Kim, H. R., Rojas, C., Syrigos, K., Hayashi, H., Haridass, A., Cortinovis, D., Bruno, D., Kimmich, M., Calles, A., ... De Ruysscher, D. (2026). Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial. Nature Cancer, 7(7), 1121-1132. https://doi.org/10.1038/s43018-026-01161-y

Willmann, J., Dee, E. C., Hendriks, L. E. L., Dimitriou, N. M., Jongbloed, M., Schoenfeld, A. J., Drilon, A., Ganesh, K., Zhang, Y. H., Feldman, J., Werner, R., Opitz, I., Carrot-Zhang, J., Schultz, N., Veeraraghavan, H., Jones, D. R., Awad, M., Rudin, C. M., Popat, S., ... Iyengar, P. (2026). Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies. Journal of Clinical Oncology, 44(16), 1540-1552. https://doi.org/10.1200/JCO-25-01958